B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CASR

MOLECULAR TARGET

calcium sensing receptor

UniProt: P41180NCBI Gene: 8466 compounds

CASR (calcium sensing receptor) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CASR

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1fendiline2.7715
2cinacalcet2.087
3Tryptophan1.102
4Framycetin0.691
5neomycin0.691
6Spermine0.691

About CASR as a Drug Target

CASR (calcium sensing receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented CASR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CASR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.